APA (7th ed.) Citation

Bergemalm, D., Füchtbauer, D., Rejller, M., Davíðsdóttir, L., Fejrskov, A., Hedin, C. R., . . . Høivik, M. (2026). NORDTREAT: A randomised, multicentre, biomarker-strategy design, open-label, controlled trial of top-down versus clinical management in newly diagnosed IBD. Journal of Crohn's & Colitis, 20, i8.

Chicago Style (17th ed.) Citation

Bergemalm, D., et al. "NORDTREAT: A Randomised, Multicentre, Biomarker-strategy Design, Open-label, Controlled Trial of Top-down Versus Clinical Management in Newly Diagnosed IBD." Journal of Crohn's & Colitis 20 (2026): i8.

MLA (9th ed.) Citation

Bergemalm, D., et al. "NORDTREAT: A Randomised, Multicentre, Biomarker-strategy Design, Open-label, Controlled Trial of Top-down Versus Clinical Management in Newly Diagnosed IBD." Journal of Crohn's & Colitis, vol. 20, 2026, p. i8.